Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $465.9500 (-1.94%) ($465.9500 - $465.9500) on Wed. Mar. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 70 | Latest Price | $465.9500(-1.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 5.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(49%) IVW(42%) IWF(42%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.205% in a week (0% probabilities). VIXM(-24%) VXX(-11%) TLT(-5%) SHY(-1%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $479.52(-2.83%) | 10 Day Moving Average | $469.99(-0.86%) | 20 Day Moving Average | $443.27(5.12%) | To recent high | -5.8% | To recent low | 38.6% | Market Cap | $49.404b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |